These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 25825450)

  • 1. Ability to develop broadly neutralizing HIV-1 antibodies is not restricted by the germline Ig gene repertoire.
    Scheepers C; Shrestha RK; Lambson BE; Jackson KJ; Wright IA; Naicker D; Goosen M; Berrie L; Ismail A; Garrett N; Abdool Karim Q; Abdool Karim SS; Moore PL; Travers SA; Morris L
    J Immunol; 2015 May; 194(9):4371-8. PubMed ID: 25825450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.
    Hicar MD; Chen X; Kalams SA; Sojar H; Landucci G; Forthal DN; Spearman P; Crowe JE
    Mol Immunol; 2016 Feb; 70():94-103. PubMed ID: 26748387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the benefits of sin: can greater understanding of the 1F7-idiotypic repertoire freeze enhance HIV vaccine development?
    Parsons MS; Muller S; Kohler H; Grant MD; Bernard NF
    Hum Vaccin Immunother; 2013 Jul; 9(7):1532-8. PubMed ID: 23571168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inferred Allelic Variants of Immunoglobulin Receptor Genes: A System for Their Evaluation, Documentation, and Naming.
    Ohlin M; Scheepers C; Corcoran M; Lees WD; Busse CE; Bagnara D; Thörnqvist L; Bürckert JP; Jackson KJL; Ralph D; Schramm CA; Marthandan N; Breden F; Scott J; Matsen Iv FA; Greiff V; Yaari G; Kleinstein SH; Christley S; Sherkow JS; Kossida S; Lefranc MP; van Zelm MC; Watson CT; Collins AM
    Front Immunol; 2019; 10():435. PubMed ID: 30936866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse recombinant HIV-1 Envs fail to activate B cells expressing the germline B cell receptors of the broadly neutralizing anti-HIV-1 antibodies PG9 and 447-52D.
    McGuire AT; Glenn JA; Lippy A; Stamatatos L
    J Virol; 2014 Mar; 88(5):2645-57. PubMed ID: 24352455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development.
    Zhang Y; Yuan T; Li J; Zhang Y; Xu J; Shao Y; Chen Z; Zhang MY
    AIDS; 2013 Oct; 27(16):2529-39. PubMed ID: 24100711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
    Yuan T; Li J; Zhang MY
    MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antibody repertoires produced by HIV-1 infection, other chronic and acute infections, and systemic autoimmune disease.
    Breden F; Lepik C; Longo NS; Montero M; Lipsky PE; Scott JK
    PLoS One; 2011 Mar; 6(3):e16857. PubMed ID: 21479208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse marginal zone B cells harbor specificities similar to human broadly neutralizing HIV antibodies.
    Pujanauski LM; Janoff EN; McCarter MD; Pelanda R; Torres RM
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1422-7. PubMed ID: 23288906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different pattern of immunoglobulin gene usage by HIV-1 compared to non-HIV-1 antibodies derived from the same infected subject.
    Li L; Wang XH; Banerjee S; Volsky B; Williams C; Virland D; Nadas A; Seaman MS; Chen X; Spearman P; Zolla-Pazner S; Gorny MK
    PLoS One; 2012; 7(6):e39534. PubMed ID: 22761815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1.
    Gawron MA; Duval M; Carbone C; Jaiswal S; Wallace A; Martin JC; Dauphin A; Brehm MA; Greiner DL; Shultz LD; Luban J; Cavacini LA
    J Immunol; 2019 Feb; 202(3):799-804. PubMed ID: 30593536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical steps for computational inference of the 3'-end of novel alleles of immunoglobulin heavy chain variable genes - illustrated by an allele of IGHV3-7.
    Thörnqvist L; Ohlin M
    Mol Immunol; 2018 Nov; 103():1-6. PubMed ID: 30172112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
    Andrabi R; Su CY; Liang CH; Shivatare SS; Briney B; Voss JE; Nawazi SK; Wu CY; Wong CH; Burton DR
    Immunity; 2017 Sep; 47(3):524-537.e3. PubMed ID: 28916265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies VRC01 and 10E8 neutralize HIV-1 with high breadth and potency even with Ig-framework regions substantially reverted to germline.
    Georgiev IS; Rudicell RS; Saunders KO; Shi W; Kirys T; McKee K; O'Dell S; Chuang GY; Yang ZY; Ofek G; Connors M; Mascola JR; Nabel GJ; Kwong PD
    J Immunol; 2014 Feb; 192(3):1100-1106. PubMed ID: 24391217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human antibody variable region gene usage in HIV-1 infection.
    Wisnewski A; Cavacini L; Posner M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):31-8. PubMed ID: 8528730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shaping of human germline IgH repertoires revealed by deep sequencing.
    Larimore K; McCormick MW; Robins HS; Greenberg PD
    J Immunol; 2012 Sep; 189(6):3221-30. PubMed ID: 22865917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the horse V(H) repertoire and comparison with the human IGHV germline genes, and sheep, cattle and pig V(H) sequences.
    Almagro JC; Martinez L; Smith SL; Alagon A; Estevez J; Paniagua J
    Mol Immunol; 2006 Apr; 43(11):1836-45. PubMed ID: 16337682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human immunoglobulin heavy variable genes.
    Pallarès N; Lefebvre S; Contet V; Matsuda F; Lefranc MP
    Exp Clin Immunogenet; 1999; 16(1):36-60. PubMed ID: 10087405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long antibody HCDR3s from HIV-naïve donors presented on a PG9 neutralizing antibody background mediate HIV neutralization.
    Willis JR; Finn JA; Briney B; Sapparapu G; Singh V; King H; LaBranche CC; Montefiori DC; Meiler J; Crowe JE
    Proc Natl Acad Sci U S A; 2016 Apr; 113(16):4446-51. PubMed ID: 27044078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 receptor binding site-directed antibodies using a VH1-2 gene segment orthologue are activated by Env trimer immunization.
    Navis M; Tran K; Bale S; Phad GE; Guenaga J; Wilson R; Soldemo M; McKee K; Sundling C; Mascola J; Li Y; Wyatt RT; Karlsson Hedestam GB
    PLoS Pathog; 2014 Aug; 10(8):e1004337. PubMed ID: 25166308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.